Endoscopic Retrograde Cholangiopancreatography Market - Global Forecast 2025-2032

The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market is experiencing steady growth as hospitals and clinics increasingly adopt technologically advanced solutions for diagnosing and managing complex hepatobiliary and pancreatic conditions. Seamlessly integrating diagnostics with minimally invasive therapies, ERCP is at the forefront of modern gastroenterological care.

Market Snapshot: Endoscopic Retrograde Cholangiopancreatography Market Growth

The global ERCP market expanded from USD 2.05 billion in 2024 to USD 2.21 billion in 2025 and is projected to maintain a compounded annual growth rate (CAGR) of 7.86%, reaching USD 3.77 billion by 2032. This positive trajectory reflects surging clinical demand, adoption of precision imaging technologies, and continuous investment in advanced endoscopic systems across both established and emerging healthcare markets.

Scope & Segmentation

• Procedure Types: Diagnostic (Cholangiography, Pancreatography) Therapeutic (Sphincterotomy, Stent Placement, Stone Extraction)
• Products: Accessories Endoscope Systems Imaging Systems (Light Sources, Video Processors)
• Applications: Biliary System Disorders (Gallstones, Leaks, Strictures) Pancreatic System Disorders (Pancreatitis, Tumors)
• End Users: Ambulatory Surgical Centers Hospitals Specialty Clinics
• Regions: Americas (North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru) Europe, Middle East & Africa (Europe: United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland; Middle East: United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel; Africa: South Africa, Nigeria, Egypt, Kenya) Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Leading Companies: Olympus Corporation Boston Scientific Corporation Medtronic plc Fujifilm Holdings Corporation HOYA Corporation KARL STORZ SE & Co. KG Cook Medical LLC CONMED Corporation Ambu A/S Stryker Corporation

Key Takeaways for Senior Decision-Makers

• ERCP has evolved from a diagnostic tool to an integrated platform supporting both high-definition imaging and advanced therapeutic intervention, raising clinical efficiency and patient safety standards.
• Investment in digital imaging, next-generation endoscopes, and modular accessory toolkits drives procedure success while supporting rapid device adaptation across diverse healthcare facilities.
• Shifts toward outpatient and ambulatory surgical models are boosting demand for portable systems and streamlined procedures, responding to calls for shorter recovery times and higher patient throughput.
• End users in all market segments are leveraging ERCP’s capabilities to consolidate interventional services and optimize resources, from large academic hospitals to specialized clinics.
• Collaborations between device manufacturers, software developers, and healthcare providers are creating integrated environments that support analytics-driven process improvement and ongoing innovation.

Tariff Impact: Navigating New US Regulatory Dynamics

Recent tariff changes in the United States are creating additional cost layers for ERCP equipment procurers, compelling manufacturers to adapt supply strategies and diversify sourcing. Hospitals and surgical centers face unpredictable capital equipment expenses, leading to a focus on local assembly, regional manufacturing partnerships, and agile just-in-time inventory management. This environmental shift encourages adoption of open-architecture platforms and modular accessory designs, ensuring uninterrupted access to critical technologies and continuous patient care despite shifting trade policies.

Methodology & Data Sources

This report synthesizes data through a hybrid research model, combining primary interviews with clinicians and procurement leaders, and exhaustive secondary review from peer-reviewed publications and industry databases. Market segmentation and scenario modeling employed rigorous cross-validation and expert consensus, ensuring a high-confidence foundation for the presented findings.

Why This Report Matters

• Equips decision-makers with actionable intelligence for navigating evolving clinical practices, technology adoption trends, and manufacturing shifts driven by global regulatory changes.
• Highlights successful strategies for supply chain resilience, regional market penetration, and technology-driven integration in a rapidly developing competitive environment.
• Empowers leadership to align capital investments, workforce planning, and go-to-market initiatives with the latest industry benchmarks and payer priorities.

Conclusion

The ERCP market stands at a pivotal juncture, shaped by technology, regulatory shifts, and changing care delivery models. Strategic adaptation and ongoing innovation will be key to unlocking value for providers and patients alike.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.